Panakès Partners

Panakès Partners operates as a Milan-based Venture Capital firm established in 2015 by industry veterans Fabrizio Landi, Alessio Beverina, and Diana Saraceni. With approximately €250 million under management across two funds, the firm has positioned itself as a significant investor in the life sciences sector. The name draws inspiration from the Greek goddess Panacea (Πανάκεια), who symbolized universal healing—reflecting the company's mission to support medical innovations that address genuine healthcare challenges and improve patient outcomes worldwide.

The investment approach at Panakès extends far beyond mere financial backing, as the firm provides comprehensive support through its extensive network of clinical experts and industry specialists. This ecosystem enables portfolio companies to accelerate their development trajectories and navigate the complex healthcare landscape more effectively. Panakès has cultivated strategic relationships with selected industrial partners, creating valuable pathways for their founders to expand market reach and enhance product development capabilities. This collaborative framework represents a significant advantage for early-stage companies seeking to transform innovative concepts into commercially viable medical solutions.

At the core of Panakès' investment philosophy lies a profound belief in human potential and team dynamics. The firm meticulously evaluates the strength, dedication, and vision of founding teams, recognizing that exceptional leadership serves as a critical determinant of investment success. As an active investor, Panakès commits to working alongside entrepreneurs throughout their growth journey, providing hands-on guidance and leveraging their connections to overcome challenges and capitalize on opportunities. This partnership-oriented approach has enabled the firm to build a diverse portfolio of companies developing revolutionary medical technologies across various therapeutic areas and diagnostic fields.

The firm's mission extends beyond financial returns to encompass broader societal impact through investments that address significant medical needs. By focusing on innovations that can save lives and enhance quality of life for both patients and caregivers, Panakès pursues a dual objective of generating substantial returns for investors while contributing meaningfully to healthcare advancement. This alignment between financial and social objectives positions the firm at the forefront of impact investing in healthcare, where cutting-edge technologies and compassionate care intersect to create sustainable value. Through this approach, Panakès continues to identify and nurture the next generation of transformative medical companies across Europe and beyond.